Trials / Completed
CompletedNCT03299829
A Retrospective Study to Assess the Clinical Efficacy and Safety of Trientine in Wilson's Disease Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 48 (actual)
- Sponsor
- Excelsior · Industry
- Sex
- All
- Age
- 3 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a retrospective study to assess the clinical efficacy and safety of trientine in Wilson's disease patients
Detailed description
In this retrospective study, the investigators will collect and analyze data from reviewing medical history files of larger and long-term follow-up cohorts with Wilson's disease in Taiwan to assess the efficacy and safety of Trientine in Taiwanese Wilson's Disease patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Trientine | Trientine is a chelating agent for removing the copper from the body |
Timeline
- Start date
- 2018-01-10
- Primary completion
- 2019-06-30
- Completion
- 2019-12-30
- First posted
- 2017-10-03
- Last updated
- 2020-08-18
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT03299829. Inclusion in this directory is not an endorsement.